All Substitutes
Loading...
Disclaimer
Did you find this information helpful?
Recagon 50IU Injection
Prescription Required
Salt Composition : Follitropin Beta
Manufacturer : ORGANON INDIA LTD
Origin of Medicine : India
1 Prefilled Syringe(s)
Introduction to Recagon 50iu Injection
Recagon 50 IU contains the active compound follitropin beta. It belongs to the class of medications called gonadotropins (hormones that regulate the function of reproductive organs). It is indicated to treat infertility in women who are not ovulating (anovulation) and is also used in medically assisted reproduction programs such as in vitro fertilisation/embryo transfer (IVF/ET). It also helps males with hypogonadotropic hypogonadism (lack of male sex hormones).
It is not recommended to take this medication if you are allergic to the active substance follitropin beta and its components. Women who are pregnant or experiencing heavy or irregular vaginal bleeding are recommended not to use this medication. You need to inform your physician if you have any thyroid disorders and liver disorders. Treatment with gonadotropins may raise the chance of developing thrombosis or blood clots. Before starting treatment, consult your doctor if you or your family has a history of thrombosis or if you are significantly overweight. Tell your physician about all the medications you are taking recently before starting treatment.
Uses of Recagon 50iu Injection
- Treatment of infertility in anovulatory women and assisted reproduction program
- Hypogonadotropic hypogonadism in men
Therapeutic Effects of Recagon 50iu Injection
Recagon 50 IU contains recombinant follicle-stimulating hormone (FSH). FSH is a hormone that plays a major role in the growth and development of follicles in the ovaries and the production of sex hormones. This medicine acts by stimulating ovarian follicle growth for women having trouble with ovulation. It boosts sperm production in men with hormonal issues.
Interaction of Recagon 50iu Injection with other drugs
Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Recagon 50IU Injection and cause undesirable side effects.
More Information about Recagon 50iu Injection
- Store at 2°C - 8°C (in a refrigerator).
- Do not store the product for more than three months
- Do not freeze
- Keep children and pets out of reach.
How to consume Recagon 50iu Injection
Treatment should be started under the guidance of a healthcare provider. It is given just beneath your skin (subcutaneously), either in the abdominal wall or the upper thigh, by your healthcare provider. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition.
Safety Advices for Recagon 50iu Injection
Pregnancy
Recagon 50 IU injection is a fertility medication that helps women to get pregnant. Hence, it must be stopped after getting pregnant. Tell your physician if you are pregnant or think you may get pregnant before taking this medication.
Breast Feeding
It is unknown whether Recagon 50 IU is excreted in breast milk. Tell your doctor if you are breastfeeding before taking this medication.
Lungs
Patients with lung diseases should consult their healthcare providers before using Recagon 50 IU to ensure personalised decision-making based on their specific health conditions.
Liver
The safety of Recagon 50 IU injection for individuals with liver problems is not well established. Inform your doctor of any liver disorders before receiving this injection.
Alcohol
Alcohol use can affect reproduction by affecting the hormone system. Hence, it is not recommended to consume alcohol during this treatment. Consult your doctor for more advice.
Driving
It has negligible influence on the ability to drive or use machines. Check with your doctor for more advice.
Side Effects of Recagon 50iu Injection
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Serious
- Ovarian hyperstimulation syndrome (ovaries enlarge and leak fluid into the body)
- Blood clots
- Ovarian torsion (twisting of ovaries )
Common
- Headache
- Injection site reactions (bruising, pain, redness, swelling, and itching)
- Pelvic pain
- Stomach pain and bloating
- Acne and breast enlargement (in males)
Word of Advice
There is a possibility for a false-positive pregnancy test result (blood or urine) within ten days of taking Recagon 50 IU injection . Confirm your results with your physician. Make sure to consume foods high in protein as it promotes the overall reproductive health and the formation of eggs. Men, try to limit your intake of soy products as soy consumption may further suppress sperm production, especially in men who already have low sperm counts.
FAQs
Q 1. What is follitropin alpha? Is it the same as follitropin beta?
Both are hormonal preparations synthesised by the same process; follitropin alpha improves ovarian follicle maturation, whereas follitropin beta is a little more effective.
Q 2. Are twins possible with FSH injections?
Women who take this medication for infertility treatment have a higher likelihood of having twins compared to those who do not.
Q 3. What is the success rate of Recagon 50 IU injection?
The chances of getting pregnant with FSH injections depend upon the treatment cycle. Discuss the dose and period of treatment with your healthcare provider.
Q 4. What precautions should be taken with Recagon 50 IU injection?
Use cautiously; consult your doctor about discontinuing the therapy after getting pregnant, avoid breastfeeding, and do not consume alcohol, as it may impair its effectiveness.
Q 5. What are the side effects I may experience?
You can experience Injection site reactions (such as bruising, pain, redness, swelling, and itching), bloating, headache, and acne.
Fact Box of Recagon 50iu Injection
Molecule Name: Follitropin beta | Therapeutic class: Hormonal drugs |
Pharmacological class: Gonadotropins | Indications: Treatment of infertility in men and women
|
References
- Vetter Pharma-Fertigung GmbH & Co. K.G., U.S. Food and Drug Administration (FDA), [Revised on August 2011] [Accessed on November 2023]
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021211s011lbl.pdf
2. N.V. Organon, Electronic medicines compendium “(EMC),” [Revised on May 2006] [Accessed on 30/11/2023]
https://www.ema.europa.eu/en/documents/product-information/puregon-epar-product-information_en.pdf
3. N.V. Organon, [Revised on March 26, 2021] [Accessed on 30/11/ 2023]
https://www.organon.com/canada-en/wp-content/uploads/sites/5/2021/05/PUREGON-CI_E.pdf
4. KD Tripathi, Essentials of Medical Pharmacology, Hormones and related drugs, 7th edition, 2013, 263.
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
